Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Takeda And Lundbeck Gear Up For Big Challenge: The Brintellix Launch

17:56 EDT 1 Oct 2013 | Elsevier Business Intelligence

Lundbeck/Takeda’s newly approved antidepressant Brintellix is poised to enter the crowded, genericized antidepressant market at the end of 2013. Potential advantages in labeling include flexible dosing, lack of weight gain and lower rates of sexual...

Original Article: Takeda And Lundbeck Gear Up For Big Challenge: The Brintellix Launch

NEXT ARTICLE

More From BioPortfolio on "Takeda And Lundbeck Gear Up For Big Challenge: The Brintellix Launch"

Search BioPortfolio: